IRadimed Corporation (IRMD)
Company Info
Highlights
$739.26M
$1.55
37.51
4.46
$75.15M
$57.80M
$22.77M
$41.18 - $62.90
$71.00
2.45%
6.30
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
IRadimed Corporation (IRMD) returned 5.89% year-to-date (YTD) and 39.12% over the past 12 months. Over the past 10 years, IRMD delivered an annualized return of 12.16%, outperforming the S&P 500 benchmark at 10.85%.
IRMD
5.89%
10.78%
7.99%
39.12%
23.42%
21.95%
12.16%
^GSPC (Benchmark)
0.51%
6.15%
-2.00%
12.92%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of IRMD, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 7.65% | -8.68% | -2.65% | -0.13% | 10.78% | 5.89% | |||||||
| 2024 | -12.77% | 1.35% | 4.81% | -7.68% | 4.95% | 3.46% | 6.30% | 0.88% | 7.09% | -2.03% | 9.76% | 1.98% | 16.99% |
| 2023 | 32.20% | 4.61% | 3.66% | 5.79% | 12.97% | 1.51% | -7.98% | 5.24% | -4.02% | -8.18% | 7.85% | 9.55% | 75.37% |
| 2022 | -13.83% | 27.36% | -9.78% | -26.61% | -0.67% | 3.82% | 24.48% | -20.59% | -10.40% | -3.36% | 1.76% | -4.30% | -37.53% |
| 2021 | 8.51% | -9.86% | 15.56% | 7.45% | 0.43% | 5.75% | 14.45% | 0.30% | -0.50% | 11.10% | 20.58% | 2.69% | 102.68% |
| 2020 | 9.07% | -6.90% | -10.07% | 1.92% | 6.85% | -0.17% | -4.01% | -4.85% | 0.85% | 5.94% | 8.21% | -6.98% | -2.48% |
| 2019 | 12.10% | -8.83% | 12.36% | -10.96% | -16.55% | -2.01% | 16.77% | -19.68% | 9.59% | 20.12% | -12.95% | 6.37% | -4.42% |
| 2018 | -1.98% | -12.46% | 10.77% | 21.18% | 6.30% | 11.86% | 10.84% | 19.56% | 35.09% | -32.81% | 15.30% | -15.01% | 61.45% |
| 2017 | -17.57% | -8.74% | 6.59% | -3.37% | -5.23% | 5.52% | 14.53% | 2.54% | -4.95% | 48.44% | -2.10% | 8.60% | 36.49% |
| 2016 | -30.61% | -8.33% | 7.46% | -14.56% | 13.26% | 17.37% | -11.03% | -3.56% | -9.00% | -44.38% | 16.93% | 0.45% | -60.40% |
| 2015 | 13.49% | -0.96% | 5.03% | 6.37% | 19.07% | 20.63% | 6.57% | -3.63% | 1.92% | 8.79% | 17.02% | -9.61% | 117.29% |
| 2014 | -7.78% | 18.29% | -35.09% | 3.71% | 21.32% | 46.26% | 30.30% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 83, IRMD is among the top 17% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for IRadimed Corporation (IRMD) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
IRadimed Corporation provided a 1.11% dividend yield over the last twelve months, with an annual payout of $0.64 per share.
| Period | TTM | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Dividend | $0.64 | $0.45 | $1.68 | $1.00 |
Dividend yield | 1.11% | 0.82% | 3.54% | 3.53% |
Monthly Dividends
The table displays the monthly dividend distributions for IRadimed Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.17 | $0.00 | $0.00 | $0.17 | $0.34 | |||||||
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.45 |
| 2023 | $0.00 | $1.05 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.63 | $1.68 |
| 2022 | $1.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.00 |
Dividend Yield & Payout
Dividend Yield
IRadimed Corporation has a dividend yield of 1.11%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
IRadimed Corporation has a payout ratio of 37.43%, which is quite average when compared to the overall market. This suggests that IRadimed Corporation strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the IRadimed Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the IRadimed Corporation was 75.83%, occurring on Apr 5, 2017. Recovery took 369 trading sessions.
The current IRadimed Corporation drawdown is 7.07%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -75.83% | Nov 12, 2015 | 351 | Apr 5, 2017 | 369 | Sep 21, 2018 | 720 |
| -56.72% | Oct 1, 2018 | 370 | Mar 20, 2020 | 330 | Jul 13, 2021 | 700 |
| -49.38% | Mar 29, 2022 | 138 | Oct 13, 2022 | 504 | Oct 16, 2024 | 642 |
| -40.21% | Aug 22, 2014 | 20 | Sep 19, 2014 | 65 | Dec 22, 2014 | 85 |
| -27.28% | Jan 5, 2022 | 16 | Jan 27, 2022 | 8 | Feb 8, 2022 | 24 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of IRadimed Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of IRadimed Corporation, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 2.4% positive surprise.
Valuation
The Valuation section provides an overview of how IRadimed Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for IRMD, comparing it with other companies in the Medical Devices industry. Currently, IRMD has a P/E ratio of 37.5. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for IRMD compared to other companies in the Medical Devices industry. IRMD currently has a PEG ratio of 4.5. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for IRMD relative to other companies in the Medical Devices industry. Currently, IRMD has a P/S ratio of 9.8. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for IRMD in comparison with other companies in the Medical Devices industry. Currently, IRMD has a P/B value of 8.2. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |